These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27607583)

  • 21. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
    Isenberg JS; Pappan LK; Romeo MJ; Abu-Asab M; Tsokos M; Wink DA; Frazier WA; Roberts DD
    Ann Surg; 2008 Jan; 247(1):180-90. PubMed ID: 18156939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
    Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
    Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors.
    Kaur S; Soto-Pantoja DR; Stein EV; Liu C; Elkahloun AG; Pendrak ML; Nicolae A; Singh SP; Nie Z; Levens D; Isenberg JS; Roberts DD
    Sci Rep; 2013; 3():1673. PubMed ID: 23591719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSP1-CD47-SIRPα signaling facilitates the development of endometriosis by mediating the survival of ectopic endometrium.
    Liu Y; Li M; Wei C; Tang L; Sheng Y; Liu Y; Li D; Ding D; Qiu J; Zhu X
    Am J Reprod Immunol; 2020 Jun; 83(6):e13236. PubMed ID: 32196807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TSP1 ameliorates age-related macular degeneration by regulating the STAT3-iNOS signaling pathway.
    Li J; He J; Zhang X; Li J; Zhao P; Fei P
    Exp Cell Res; 2020 Mar; 388(1):111811. PubMed ID: 31899207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
    Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.
    Rogers NM; Roberts DD; Isenberg JS
    Ann Surg; 2013 Jul; 258(1):184-91. PubMed ID: 23275312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation by CD47 and thrombospondin-1 of extramedullary erythropoiesis in mouse spleen.
    Banerjee R; Meyer TJ; Cam MC; Kaur S; Roberts DD
    Elife; 2024 Jul; 12():. PubMed ID: 38979889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.
    Venkatraman L; Tucker-Kellogg L
    Liver Int; 2013 Oct; 33(9):1386-97. PubMed ID: 23799952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease.
    Rogers NM; Sharifi-Sanjani M; Csányi G; Pagano PJ; Isenberg JS
    Matrix Biol; 2014 Jul; 37():92-101. PubMed ID: 24418252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.
    Stirling ER; Terabe M; Wilson AS; Kooshki M; Yamaleyeva LM; Alexander-Miller MA; Zhang W; Miller LD; Triozzi PL; Soto-Pantoja DR
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36418073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and function.
    Koduru SV; Sun BH; Walker JM; Zhu M; Simpson C; Dhodapkar M; Insogna KL
    J Biol Chem; 2018 Sep; 293(39):15055-15069. PubMed ID: 30082316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
    Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine.
    Kale A; Rogers NM; Ghimire K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.
    Jeanne A; Sarazin T; Charlé M; Kawecki C; Kauskot A; Hedtke T; Schmelzer CEH; Martiny L; Maurice P; Dedieu S
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e1-e17. PubMed ID: 33232198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.
    Csányi G; Yao M; Rodríguez AI; Al Ghouleh I; Sharifi-Sanjani M; Frazziano G; Huang X; Kelley EE; Isenberg JS; Pagano PJ
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2966-73. PubMed ID: 23087362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.
    Wang Y; Wang S; Sheibani N
    Microvasc Res; 2006 May; 71(3):143-51. PubMed ID: 16624339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.
    Kaur S; Singh SP; Elkahloun AG; Wu W; Abu-Asab MS; Roberts DD
    Matrix Biol; 2014 Jul; 37():49-59. PubMed ID: 24887393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells.
    Fei P; Zaitoun I; Farnoodian M; Fisk DL; Wang S; Sorenson CM; Sheibani N
    PLoS One; 2014; 9(12):e116423. PubMed ID: 25548916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis.
    Gao L; Chen K; Gao Q; Wang X; Sun J; Yang YG
    Oncotarget; 2017 Apr; 8(14):22406-22413. PubMed ID: 27283989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.